Skip to content

A study to compare the efficacy of sevoflurane versus propofol in patients undergoing brachial plexus repair surgery

A comparative randomized control study of induction and maintenance of general anaesthesia with sevoflurane versus propofol without neuromuscular blockers for brachial plexus repair surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038639
Enrollment
60
Registered
2021-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S143- Injury of brachial plexus

Interventions

Intervention1: Sevoflurane: Inhalational induction with 8% Sevoflurane and maintenance with 3% sevoflurane throughout the procedure Control Intervention1: Propofol: Intravenous induction with 3mg/kg

Sponsors

Dr Mhonisha B
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Adults of age between 18 to 45 years, 2) ASA grade I and II,3)Mallampatti grade 1 and 2, 4)Informed consent from the patient, 5)Patient diagnosed with brachial plexus injury undergoing brachial plexus repair surgery

Exclusion criteria

Exclusion criteria: 1)patient not giving consent, 2)patient having coexisting cardiovascular,renal,respiratory,endocrinal and metabolic disorders 3)patient whose physical characteristics suggest difficult intubation (MP III and IV) 4)Non brachial plexus repair surgeries

Design outcomes

Primary

MeasureTime frame
Ease of intubation in both the groups Hemodynamic stability in both groupsTimepoint: Baseline,1minute, 5 minutes, 10 minutes, 20 minutes, 1 hour, 2 hour and 3 hours

Secondary

MeasureTime frame
Emergence timeTimepoint: After surgical procedure

Countries

India

Contacts

Public ContactDr Mhonisha B

Ganga Medical Centre and Hospitals

drboopathiv@yahoo.co.in9443338677

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026